RxDoctor Payments Data

Edward Porubsky, MD

Facial Plastic Surgery · Evans, GANPI 1043286313

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.9% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 26.1% of the total.

$1,809in general payments, 2019–2025

Across 65 payments — averaging $27.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$471
  • Integra Lifesciences Corporation$320
  • Optinose US, Inc.$267
  • Sanofi$213
  • Jazz Pharmaceuticals Inc.$130
  • GSK$112
  • plus $296 from 6 others

What the payments were for

  • Food & beverage$1,75397%
  • Education$563%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few facial plastic surgery providers in Georgiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$219,324
Medicare patients
1,037
Services billed
5,860

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab13$48,648
Ipratropium Bromide260$7,301
Fluticasone Propionate257$3,177
Azelastine Hcl144$3,057
Azelastine-FluticasoneAzelastine/Fluticasone18$2,206
Omeprazole98$904
Cefdinir34$522
Dexamethasone Sodium Phosphate12$495
Famotidine51$478
Ofloxacin22$467
Doxycycline Hyclate51$413
Montelukast Sodium49$369
Nystatin15$316
Methylprednisolone41$229
Diazepam20$179

Paid to pharmacies, not to this prescriber.

Other facial plastic surgery in Evans

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →